PET and SPECT in medication development

SJ Gatley; F Carroll

doi:doi:10.1002/ddr.10218

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

PET and SPECT in medication development

Gatley, SJ., & Carroll, F. (Eds.) (2003). PET and SPECT in medication development. Drug Development Research, 59(2), 191-193. https://doi.org/10.1002/ddr.10218

Copy citation

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults

Article

Pregnancy rates and clinical outcomes among women living with HIV enrolled in HPTN 052

Article

The influence of mediators on the relationship between antenatal opioid agonist exposure and the severity of neonatal opioid withdrawal syndrome

Article

PET and SPECT in medication development

Publications Info

Recent Publications

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults

Pregnancy rates and clinical outcomes among women living with HIV enrolled in HPTN 052

The influence of mediators on the relationship between antenatal opioid agonist exposure and the severity of neonatal opioid withdrawal syndrome

A scoping review of empirical research on prescription drug promotion

Partner With Us

Site